Nanda Gruben

669 total citations
9 papers, 551 citations indexed

About

Nanda Gruben is a scholar working on Epidemiology, Molecular Biology and Surgery. According to data from OpenAlex, Nanda Gruben has authored 9 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Nanda Gruben's work include Liver Disease Diagnosis and Treatment (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Nanda Gruben is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Nanda Gruben collaborates with scholars based in Netherlands, United States and Belgium. Nanda Gruben's co-authors include Debby P.Y. Koonen, Marten H. Hofker, Ronit Shiri‐Sverdlov, Niels Kloosterhuis, Alain de Bruin, Pascal P. H. Hommelberg, Fareeba Sheedfar, Sameh A. Youssef, Robert Kleemann and Martine C. Morrison and has published in prestigious journals such as PLoS ONE, Hepatology and Atherosclerosis.

In The Last Decade

Nanda Gruben

9 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nanda Gruben Netherlands 8 357 195 169 116 64 9 551
Fareeba Sheedfar Netherlands 11 327 0.9× 262 1.3× 252 1.5× 110 0.9× 79 1.2× 14 700
Ludmila Kazdová Czechia 13 246 0.7× 201 1.0× 184 1.1× 112 1.0× 90 1.4× 24 584
Marta Chacińska Poland 7 201 0.6× 248 1.3× 308 1.8× 125 1.1× 98 1.5× 8 700
Laura M. Laiglesia Spain 11 202 0.6× 263 1.3× 144 0.9× 83 0.7× 73 1.1× 13 611
K. Staiger Germany 9 234 0.7× 218 1.1× 258 1.5× 92 0.8× 99 1.5× 11 584
Pascal P. H. Hommelberg Netherlands 10 212 0.6× 280 1.4× 212 1.3× 57 0.5× 55 0.9× 11 543
Andrea Ahnmark Sweden 10 293 0.8× 299 1.5× 246 1.5× 98 0.8× 97 1.5× 16 636
Vivian A. Paschoal United States 14 201 0.6× 303 1.6× 232 1.4× 70 0.6× 67 1.0× 19 616
Klaus Tödter Germany 11 193 0.5× 234 1.2× 235 1.4× 105 0.9× 103 1.6× 13 577
Annette Brandt Austria 18 414 1.2× 252 1.3× 289 1.7× 202 1.7× 72 1.1× 43 741

Countries citing papers authored by Nanda Gruben

Since Specialization
Citations

This map shows the geographic impact of Nanda Gruben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanda Gruben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanda Gruben more than expected).

Fields of papers citing papers by Nanda Gruben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanda Gruben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanda Gruben. The network helps show where Nanda Gruben may publish in the future.

Co-authorship network of co-authors of Nanda Gruben

This figure shows the co-authorship network connecting the top 25 collaborators of Nanda Gruben. A scholar is included among the top collaborators of Nanda Gruben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanda Gruben. Nanda Gruben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gruben, Nanda, Leen Catrysse, Martijn Koehorst, et al.. (2021). The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis. Molecular Metabolism. 54. 101349–101349. 55 indexed citations
2.
Wolfs, Marcel G. M., Nanda Gruben, Sander S. Rensen, et al.. (2015). Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity. Nutrition and Diabetes. 5(2). e146–e146. 47 indexed citations
3.
Gruben, Nanda, Niels Kloosterhuis, Marijke Schreurs, et al.. (2015). Cholesterol-Induced Hepatic Inflammation Does Not Underlie the Predisposition to Insulin Resistance in Dyslipidemic Female LDL Receptor Knockout Mice. Journal of Diabetes Research. 2015. 1–12. 7 indexed citations
4.
Heijden, Roel A. van der, Fareeba Sheedfar, Martine C. Morrison, et al.. (2015). High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice. Aging. 7(4). 256–268. 227 indexed citations
5.
Gruben, Nanda, Ronit Shiri‐Sverdlov, Debby P.Y. Koonen, & Marten H. Hofker. (2014). Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(11). 2329–2343. 122 indexed citations
6.
Gruben, Nanda, Niels Kloosterhuis, Henk F. van der Molen, et al.. (2014). Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice. PLoS ONE. 9(4). e96345–e96345. 36 indexed citations
7.
Schreurs, Marijke, Marcela Aparicio-Vergara, Fareeba Sheedfar, et al.. (2013). Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice. Atherosclerosis. 232(2). 390–396. 20 indexed citations
8.
Hommelberg, Pascal P. H., Marcela Aparicio-Vergara, Marijke Schreurs, et al.. (2012). Impaired Shedding of TNF Receptor 1 Aggravates High Fat Diet Induced Non-Alcoholic Fatty Liver Disease But Does Not Cause Insulin Resistance in Mice. Hepatology. 56. 1 indexed citations
9.
Aparicio-Vergara, Marcela, Pascal P. H. Hommelberg, Marijke Schreurs, et al.. (2012). Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in a Murine Model. Hepatology. 57(2). 566–576. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fareeba Sheedfar Breakdown of academic impact, for papers by Ludmila Kazdová Breakdown of academic impact, for papers by Marta Chacińska Breakdown of academic impact, for papers by Laura M. Laiglesia Breakdown of academic impact, for papers by K. Staiger Breakdown of academic impact, for papers by Pascal P. H. Hommelberg Breakdown of academic impact, for papers by Andrea Ahnmark Breakdown of academic impact, for papers by Vivian A. Paschoal Breakdown of academic impact, for papers by Klaus Tödter Breakdown of academic impact, for papers by Annette Brandt
Rankless by CCL
2026